CNBX Pharmaceuticals Inc.
CNBX· OTC
CNBXCNBX Pharmaceuticals Inc.
Filed Apr 13, 2012 · 10-Q · 44 days after period end · 0001303681-12-000048
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Net Income | -$1.85K | $2.98K |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CNBX Pharmaceuticals Inc. · CIK 1343009 · Engraved from SEC EDGAR
ended Feb 29, 2012 · filed Apr 13, 2012 · 44 d after period end
